title: Inhibition of neurotensin-induced miosis by blockade of ocular dopamine pathways.
abstract: In previous work we have determined that intracameral (IC) administration of neurotensin (NT) produces strong miosis in rabbits. However, the pharmacological mechanism of this response remains undetermined. Blockade of alpha and beta-adrenoceptor subtypes with phenoxybenzamine and propranolol, blockade of M1 muscarinic receptors with atropine or blockade of mu opioid receptors with naloxone did not affect NT-induced miosis. Of interest however was the observation that destruction of ocular dopamine (DA) nerve endings with 6-hydroxydopamine (6-OHDA) + desmethylimipramine (DMI), or blockade of D-2 DA receptors with haloperidol significantly inhibited the miotic response to IC NT. These findings indicate that an intact iridic DA pathway is required for the expression of NT-induced miosis.
authors.affiliation: Department of Medicine, University of Southern California, Los Angeles.
authors.forename: D E
authors.initials: DE
authors.lastname: Hernandez
authors.forename: L
authors.initials: L
authors.lastname: Jennes
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000502:physiology; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D005123:Eye / Q000648:ultrastructure*; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007498:Iris / Q000294:innervation; D015877:Miosis / Q000188:drug therapy*; D018727:Muscarinic Antagonists; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists; D009411:Nerve Endings / Q000502:physiology; D009496:Neurotensin / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000502:physiology; D016627:Oxidopamine; D011817:Rabbits; D017450:Receptors, Opioid, mu
chemical_list: D018492:Dopamine Antagonists; D006892:Hydroxydopamines; D018727:Muscarinic Antagonists; D009292:Narcotic Antagonists; D018377:Neurotransmitter Agents; D017450:Receptors, Opioid, mu; D009270:Naloxone; D009496:Neurotensin; D001285:Atropine; D016627:Oxidopamine; D006220:Haloperidol; D003891:Desipramine; D004298:Dopamine